Recombinant anti-2019-nCoV NP ScFv Antibody
Beta LifeScience
SKU/CAT #: BLSN-008M
Recombinant anti-2019-nCoV NP ScFv Antibody
Beta LifeScience
SKU/CAT #: BLSN-008M
Collections: Antibodies
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Host Species | Recombinant |
Background | Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. |
Description | Recombinant anti-2019-nCoV NP ScFv Antibody was cultrued in vitro under conditions free from animal derived components. |
Source | In vitro |
Purity | ≥95 % |
Formulation | 2019-nCoV NP ScFv antibody is supplied in 20mM PB, 150mM NaCl, pH 7.4. |
Stability | 2019-nCoV NP ScFv is stable up to 24 months from manufacturing at <-20 °C. |
Reactivity | 80-120 % compared to the reference sample in an ELISA test. |
Clone | 3Z5 |
Specificity | This Antibody recognizes 2019-nCoV Nucleocapsid Protein |
Concentration | 5.0 mg/ml (+/- 10 %) |